LAVIV - 75935-001-01 - (azficel-T)

Alphabetical Index


Drug Information of LAVIV

Product NDC: 75935-001
Proprietary Name: LAVIV
Non Proprietary Name: azficel-T
Active Ingredient(s): 15000000    1/mL & nbsp;   azficel-T
Administration Route(s): INTRADERMAL
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of LAVIV

Product NDC: 75935-001
Labeler Name: Fibrocell Technologies, Inc.
Product Type: CELLULAR THERAPY
FDA Application Number: BLA125348
Marketing Category: BLA
Start Marketing Date: 20110715

Package Information of LAVIV

Package NDC: 75935-001-01
Package Description: 2 VIAL in 1 PACKAGE (75935-001-01) > 1 mL in 1 VIAL (75935-001-02)

NDC Information of LAVIV

NDC Code 75935-001-01
Proprietary Name LAVIV
Package Description 2 VIAL in 1 PACKAGE (75935-001-01) > 1 mL in 1 VIAL (75935-001-02)
Product NDC 75935-001
Product Type Name CELLULAR THERAPY
Non Proprietary Name azficel-T
Dosage Form Name INJECTION, SUSPENSION
Route Name INTRADERMAL
Start Marketing Date 20110715
Marketing Category Name BLA
Labeler Name Fibrocell Technologies, Inc.
Substance Name AZFICEL-T
Strength Number 15000000
Strength Unit 1/mL
Pharmaceutical Classes Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Fibroblasts [Chemical/Ingredient]

Complete Information of LAVIV


General Information